Evidence map›Paper›PMID 31327001›Full record

ArticleBrain : a journal of neurology2019

Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size.

Diana Le Duc, Cecilia Giulivi, Susan M Hiatt, Eleonora Napoli, Alexios Panoutsopoulos, Angelo Harlan De Crescenzo, Urania Kotzaeridou, Steffen Syrbe, Evdokia Anagnostou, Meron Azage and 37 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Molecular basis of autism spectrum disorders.Molecular biology reports · 2025
    Review
  10. mAutism research : official journal of the International Society for Autism Research · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors at 16 institutions in 5 countries.

Diana Le DucInstitute of Human Genetics, University Medical Center Leipzig, Leipzig, Germany.
Cecilia GiuliviDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Susan M HiattHudsonAlpha Institute for Biotechnology, 601 Genome Way, Huntsville, AL, USA.
Eleonora NapoliDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Alexios PanoutsopoulosDepartment of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, USA.
Angelo Harlan De CrescenzoDepartment of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, USA.
Urania KotzaeridouDivision of Child Neurology and Inherited Metabolic Diseases, Centre for Paediatrics and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, Heidelberg, Germany.
Steffen SyrbeDivision of Child Neurology and Inherited Metabolic Diseases, Centre for Paediatrics and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, Heidelberg, Germany.
Evdokia AnagnostouBloorview Research Institute, University of Toronto, Toronto, Canada.
Meron AzageDepartment of Pediatrics, Ochsner Health System and University of Queensland, New Orleans, LA, USA.
Renee BendGreenwood Genetic Center, Greenwood, SC, USA.
Amber BegtrupGeneDx, Clinical Genomics, 207 Perry Parkway Gaithersburg, MD, USA.
Natasha J BrownDepartment of Pediatrics, University of Melbourne, VIC, Australia.
Benjamin BüttnerInstitute of Human Genetics, University Medical Center Leipzig, Leipzig, Germany.
Megan T ChoGeneDx, Clinical Genomics, 207 Perry Parkway Gaithersburg, MD, USA.
Gregory M CooperHudsonAlpha Institute for Biotechnology, 601 Genome Way, Huntsville, AL, USA.
Jan H DoeringDivision of Child Neurology and Inherited Metabolic Diseases, Centre for Paediatrics and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, Heidelberg, Germany.
Christèle DubourgService de Génétique Moléculaire et Génomique, CHU, Rennes, F-35033, France.
David B EvermanGreenwood Genetic Center, Greenwood, SC, USA.
Michael S HildebrandDepartment of Pediatrics, University of Melbourne, VIC, Australia.
Francis Jeshira Reynoso SantosJoe DiMaggio Children's Hospital, Hollywood, FL, USA.
Barbara KellamThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada.
Jennifer Keller-RameyGeneDx, Clinical Genomics, 207 Perry Parkway Gaithersburg, MD, USA.
Johannes R LemkeInstitute of Human Genetics, University Medical Center Leipzig, Leipzig, Germany.
Shuxi LiuGeneDx, Clinical Genomics, 207 Perry Parkway Gaithersburg, MD, USA.
Dmitriy NiyazovDepartment of Pediatrics, Ochsner Health System and University of Queensland, New Orleans, LA, USA.
Katelyn PayneRiley Hospital for Children, Indianapolis, IN, USA.
Richard PersonGeneDx, Clinical Genomics, 207 Perry Parkway Gaithersburg, MD, USA.
Chloé QuélinService de Génétique Clinique, CHU, Rennes, F-35203, France.
Rhonda E SchnurGeneDx, Clinical Genomics, 207 Perry Parkway Gaithersburg, MD, USA.
Brooke T SmithGreenwood Genetic Center, Greenwood, SC, USA.
Jonathan StroberUCSF Benioff Children's Hospital, San Francisco, CA, USA.
Susan WalkerThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada.
Mathew WallisAustin Health Clinical Genetics Service, Heidelberg, VIC, Australia.
Laurence WalshRiley Hospital for Children, Indianapolis, IN, USA.
Sandra YangGeneDx, Clinical Genomics, 207 Perry Parkway Gaithersburg, MD, USA.
Ryan K C YuenThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada.
Andreas ZieglerDivision of Child Neurology and Inherited Metabolic Diseases, Centre for Paediatrics and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, Heidelberg, Germany.
Heinrich StichtInstitute of Biochemistry, Emil-Fischer-Center, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Michael C PrideMIND Institute, University of California Davis, Sacramento, CA, USA.
Lori OroscoDepartment of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, USA.
Verónica Martínez-CerdeñoMIND Institute, University of California Davis, Sacramento, CA, USA.
Jill L SilvermanMIND Institute, University of California Davis, Sacramento, CA, USA.
Jacqueline N CrawleyMIND Institute, University of California Davis, Sacramento, CA, USA.
Stephen W SchererThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada.
Konstantinos S ZarbalisMIND Institute, University of California Davis, Sacramento, CA, USA.
Rami JamraInstitute of Human Genetics, University Medical Center Leipzig, Leipzig, Germany.
Shriners Hospitals for Children - Erie · USUniversity of California, Davis · USHeidelberg University · DELeipzig University · DEGreenwood Genetic Center · USThe University of Melbourne · AUUniversity of Toronto · CAHospital for Sick Children · CAHudsonAlpha Institute for Biotechnology · USOchsner Health System · USRiley Hospital for Children · USCentre Hospitalier Universitaire de Rennes · FRCentre National de la Recherche Scientifique · FRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEJoe DiMaggio Children's Hospital · USUCSF Benioff Children's Hospital · US

Funding

South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
Rodent Behavior CoreU54HD079125 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SIMON, TONY J · 2013 to 2019
$8.5M
Genomic Diagnosis in Children with Developmental DelayUM1HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COOPER, GREGORY MICHAEL, MYERS, RICHARD M · 2013 to 2016
$7.5M
Mosaic analysis with double markers in the study of neuronal migration disordersR21MH115347 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZARBALIS, KONSTANTINOS · 2018 to 2019
$432k
Wdfy3, a novel regulator of neuronal migration and connectivityR21HD067855 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZARBALIS, KONSTANTINOS · 2011 to 2012
$422k
Antioxidants and oxidative damage in mitochondriaR01ES012691 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI GIULIVI, CECILIA · 2004 to 2004
$148k
NHGRI NIH HHS UM1 HG007301NICHD NIH HHS R21 HD067855NICHD NIH HHS U54 HD079125NIMH NIH HHS R21 MH115347
6 · The paper itself

Abstract

The underpinnings of mild to moderate neurodevelopmental delay remain elusive, often leading to late diagnosis and interventions. Here, we present data on exome and genome sequencing as well as array analysis of 13 individuals that point to pathogenic, heterozygous, mostly de novo variants in WDFY3 (significant de novo enrichment P = 0.003) as a monogenic cause of mild and non-specific neurodevelopmental delay. Nine variants were protein-truncating and four missense. Overlapping symptoms included neurodevelopmental delay, intellectual disability, macrocephaly, and psychiatric disorders (autism spectrum disorders/attention deficit hyperactivity disorder). One proband presented with an opposing phenotype of microcephaly and the only missense-variant located in the PH-domain of WDFY3. Findings of this case are supported by previously published data, demonstrating that pathogenic PH-domain variants can lead to microcephaly via canonical Wnt-pathway upregulation. In a separate study, we reported that the autophagy scaffolding protein WDFY3 is required for cerebral cortical size regulation in mice, by controlling proper division of neural progenitors. Here, we show that proliferating cortical neural progenitors of human embryonic brains highly express WDFY3, further supporting a role for this molecule in the regulation of prenatal neurogenesis. We present data on Wnt-pathway dysregulation in Wdfy3-haploinsufficient mice, which display macrocephaly and deficits in motor coordination and associative learning, recapitulating the human phenotype. Consequently, we propose that in humans WDFY3 loss-of-function variants lead to macrocephaly via downregulation of the Wnt pathway. In summary, we present WDFY3 as a novel gene linked to mild to moderate neurodevelopmental delay and intellectual disability and conclude that variants putatively causing haploinsufficiency lead to macrocephaly, while an opposing pathomechanism due to variants in the PH-domain of WDFY3 leads to microcephaly.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAnimalsAutophagy-Related ProteinsBrainChildChild, PreschoolFemaleGenetic VariationHumansMaleMiceMice, TransgenicNeurodevelopmental DisordersOrgan SizeProtein Structure, SecondaryAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsWDFY3 protein, humanbrain sizeintellectual disabilityneurodevelopmental delayWDFY3

Identifiers

PMID31327001
PMCPMC6736092
OpenAlexW2962917566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.